Chambers Review
Provided by Chambers
Europe
Life Sciences - Germany
Individual Editorial
Rüdiger Herrmann of Squire Patton Boggs is particularly regarded for his track record in the venture capital and biotechnology sectors. He has extensive experience advising on transactions as well as licensing, cooperation and distribution agreements. His clients include German and international biotech and pharmaceutical companies, medical research organisations and investors. Rüdiger Herrmann frequently acts on cross-border and multi-jurisdictional mandates.
